Fig. 2From: High-flow nasal oxygen vs. standard oxygen therapy for patients undergoing transcatheter aortic valve replacement with conscious sedation: a randomised controlled trialChange in arterial partial pressure of oxygen (pO2) and arterial partial pressure of carbon dioxide (pCO2) from 0 to 30Â min during transfemoral transcatheter aortic valve implantation (TAVR) in patients randomly allocated to high-flow nasal oxygen therapy (HFNT) or standard oxygen therapy (SOT)Back to article page